本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Avalo Therapeutics Inc

4.90
+0.12002.51%
盘后4.75-0.1500-3.06%16:31 EDT
成交量:2.45万
成交额:11.88万
市值:5,305.53万
市盈率:-1.00
高:4.95
开:4.83
低:4.76
收:4.78
数据加载中...
2024/07/11

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/07/09

重要事件披露

Form 8-K - Current report
2024/06/24

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/06/24

重要事件披露

Form 8-K - Current report
2024/06/24

重要事件披露

Form 8-K - Current report
2024/06/03

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/05/23

重要事件披露

Form 8-K - Current report
2024/05/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/04/23

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/29

重要事件披露

Form 8-K - Current report
2024/03/28

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

重要事件披露

Form 8-K - Current report